Bluemango
02 Aug 2017
Re: Confession Being something of a chart fanatic, Andy, would you say a rise from here might confirm a bullish double bottom formation, or is the length of time between the two troughs too long?Agree that there are some signs of recovery here, but it will need tangible evidence in the form of new contracts as we have had all the talk and promise now and the market needs more than just that. Am very impressed with focus and determination of new management, wish Haigh had been at the helm some years ago and then maybe we wouldn't be looking at such a lowly market cap now. In hindsight, it rather looks as if CJP was simply hoping big pharma would come to him and all he needed to do in the meantime was file and maintain as many patents as he could. Richard Dennis sounds a far more impressive sales guy then the company have had hitherto, hope he will aggressively go out and do the deals.
Andy Reilly
27 Jul 2017
Re: Confession 3.5p support was last hit in early March this year - a break below would be bad news as the SP would literally be in uncharted territory - selling pressure has eased a fair bit, BUT 3.5p REALLY needs to hold.
Andy Reilly
25 Jul 2017
Re: Confession C1 - goodness thats some disappointment with results today, and any suggestion of a fund raising isnt going to help the SP shorter term - very disappointing, but that seems to be what PRM does. Its not good and will take time to recover - lets hope the new strategy (CEO) starts to show some hope the way back to the SP - It took OXB quite a while to recover, and its prospects look much improved. (I would certainly have done much better to hang on there, and hold... BUT thats life. Lets hope I get another chance with OXB, and I can buy back on any weakness IF it happens - Oh well, such is investing), but a least I have a very useful amount of cash to put back to work in the market.... and I do like to hold a good amount of cash at times, even if I get my sells and buys wrong at times..... To err is alas all too human, BUT as long as I am making some money the challenge is very enjoyable.... and long term performance is very important to me. ATB to all holders... and hopefully PRM will turn around sometime soon.... it seems to be getting there (despite todays disappointment!), especially with a new CEO at the helm.
COCKY1
25 Jul 2017
Re: Confession not the only ones selling...disappointing results (again). Suspect they will need to ask for more money to keep it going for another year (before turning a profit...)
biofarmer
20 Jul 2017
Re: Confession Lombard Odier had been selling but now complete by all account.
The Potter
18 Jul 2017
Q Exactive™ HF-X Hybrid Quadrupole-Orbitrap™ Mass Spectrometer See video at:[link] TMT tenplex)
dave297
12 Jul 2017
Confession I bought some morecshares here yesterday @ under 4p-a decision I may live to regret.
The Potter
12 Jul 2017
25 July 2017 ......is the date of PRM interim results that have, until this year, been divulged in September.After another inexplicable downturn in the SP, that has been completely unwarranted considering the news emanating from PRM, my take on this is that the results must be good!Has there been some shorting in progress? The volumes seem to suggest no. But it is extremely difficult to understand why the SP continues to fall.I smell a rat, but it will be killed on 25 July, that's for sure!
The Potter
06 Jul 2017
Re: Randox stroke test milestone Hi AR,My remark that referred to "realism" was meant to point out that the milestone payment would only be a fraction of the "real" value to PRM, should the stroke test become an industry standard.Having been duped by CP on many occasions, long-term investors in PRM must be hoping that the rather short statement issued by the new team tends to underestimate the potential.In fact, I was surprised that there was no mention whatsoever of future income. After CP's hyperbole, PRM statements have been factual. However it now looks as though they could use some better PR, a point that I have made before!I always try to keep it real, but I remain as ever an optimist!
Andy Reilly
04 Jul 2017
Re: Randox stroke test milestone TP - well 'realism' is a funny old thing, but I would b down by £24,564 (30K PM @ 80p (I think it was) IF I had just hung on being 'realistic'. I have a feeling that PRM 'may be' on the turn at last, (as 'every dog has his day' (well sometimes!!)). These Bios are a tough call, but hopefully some of that 'positive vibe' can return to the SP soon... its getting there (as it is more or less in oversold territory!) ARThat 'key' 200 day EMA is nearly double the current SP... SO quite some way before the SP is in more confident territory, BUT hope and realism are rather open to interpretation I feel! Keep t real! ATB
dave297
02 Jul 2017
Re: Randox stroke test milestone Well I hope you are right Goodly & it all happens while I am still alive!A profit from my longstanding holding would be most welcome
The Potter
02 Jul 2017
Re: Randox stroke test milestone Goodly,Thank you for bringing some realism to this BB.It certainly makes a change to what has been posted recently!
goodly
02 Jul 2017
Re: Randox stroke test milestone Although the Randox milestones will be useful, the real money comes with the royalty payments in the double digits. We will see all the big global diagnostics companies license the Stoke biomarkers from Proteome Sciences, as they will require a Stroke assay on their own lab. testing platforms. The global market for a Stroke blood test is valued at $500 million to $1 billion a year. With PRM receiving a minimum of 10% of that, the current sp of 4.5p looks ridiculous.
The Potter
02 Jul 2017
Re: Randox stroke test milestone Although some sarcasm may be acceptable, the Sandox announcement could be worth far more than the £100,000 milestone payment, if the original assessment of April 2012 is still valid.
Andy Reilly
30 Jun 2017
Re: Randox stroke test milestone D297 - well a bit of positive news at last, and it saved the SP, which for the previous 2 days has sat on a downtrend - hopefully a better SP will be in the offing soon! Good news has been thin on the ground for PRM, but it may well be a case of 'every dog.... etc" So I will have a good strategic think over the weekend, and whether its a good idea to take on a bit more risk in the portfolio... Hope all goes well -
